CABA
Cabaletta Bio Inc
NASDAQ: CABA · HEALTHCARE · BIOTECHNOLOGY
$2.78
-2.80% today
Updated 2026-04-29
Market cap
$328.40M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.10
Dividend yield
—
52W range
$1 – $4
Volume
2.2M
Cabaletta Bio Inc (CABA) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-4.66M | $-4.66M | $-16.05M | $-26.77M | $-34.11M | $-46.38M | $-53.55M | $-88.22M | $-131.08M |
| Capital expenditures | $693000.00 | $693000.00 | $693000.00 | $635000.00 | $1.17M | $2.45M | $687000.00 | $2.21M | $1.23M |
| Depreciation | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | $606000.00 | $2.30M | $4.39M | $5.80M | $6.90M | $11.34M | $19.46M | $20.94M |
| Free cash flow | $-5.35M | $-5.35M | $-16.74M | $-27.41M | $-35.27M | $-48.83M | $-54.24M | $-90.43M | $-132.31M |
| Investing cash flow | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $10.09M | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-34.77M | — | $-40.62M | — | — | — |